Audience-funded nonprofit news
Next Up:
0:00
0:00
-
Listen Listen
Health
Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the makers of Wegovy and Mounjaro are seeking FDA approval for tablets.
Sponsored message
More Stories
-
Despite efforts to increase the number of mental health providers, many students say the training requirements are onerous and costly.
-
Kaiser therapists, psychologists and social workers have been picketing in California since October.
-
"Without speaking to Ryan, they denied the care he needed. They said he could control his addiction if he really wanted to.”
-
Cases of the liver infection have more than tripled since 2023. The reason is not entirely clear.
-
Officials plan to nearly double the number of machines, called “community health stations,” over the next few months.
-
The clinic will offer low-risk surgical care to low-income patients.
-
Monica Soni, Covered California’s chief medical officer, oversees an effort to hold health plans financially accountable for the quality of care they provide, including childhood vaccination rates, which have fallen in California and nationwide.
-
The Department of Health and Human Services says it will require new vaccines to be tested against a placebo, which could complicate and delay Food and Drug Administration approval of many vaccines.
-
Health insurance exchange Covered California transmitted pregnancy and abuse data during a marketing campaign. It is reviewing its practices.
-
It’s the tenth California case this year and comes amid a widening U.S. outbreak.
-
Scientists have a new clue in the mystery of why younger people are getting more colon cancer. It may have to do with a toxin produced by a common gut microbe.
-
Any Californian can now buy Naloxone, the opioid overdose reversal drug, at a steep discount through a deal Gov. Gavin Newsom's office negotiated.
